Literature DB >> 17225919

Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice.

Zuyuan Xu1, Natalie Riediger, Sheila Innis, Mohammed H Moghadasian.   

Abstract

BACKGROUND: Consumption of fish oil and n-3 fatty acids is associated with beneficial modifications in plasma lipid levels. The impact of these modifications on development of atherosclerotic lesions merits further investigation. AIM OF THE STUDY: The aim of this study was to investigate the impact of fish oil consumption on quality and quantity of lipoprotein fatty acids and its influence on atherosclerosis in apolipoprotein E-knockout (apo E-KO) mice.
METHODS: Male apo E-KO mice were treated with 1% dietary fish oil for 14 weeks. Plasma triglycerides (TG), phospholipids, (PL) and cholesteryl ester (CE) fractions were separated using thin layer chromatography. Plasma-free fatty acids (FFA) plus fatty acid contents of TG, PL, CE were determined using gas chromatography. Aortic atherosclerosis was assessed by histological and morphometrical techniques.
RESULTS: Twenty-eight fatty acids were identified in each of the four lipid compartments. High amounts of n-3 fatty acids (eicosapentaenoic (EPA), docosahexaenoic (DHA)) were found in all of these fractions. The levels of EPA and DHA increased by 400 and 150%, respectively, in FFA, TG and PL compartments; higher increases (>500 and 200%) in EPA and DHA were found in CE. This markedly decreased the n-6/n-3 ratios in FFA, TG, PL, and CE by 60, 72, 53, and 61%, respectively. These changes were accompanied by a significant increase in plasma triglyceride levels. Surprisingly, these changes did not affect atherogenesis.
CONCLUSIONS: Elevated levels of EPA and DHA do not appear to prevent development of atherosclerotic plaques in this model. Longer studies warrant investigation of the direct benefits of these fatty acids against myocardial damage as clinical consequences of advanced atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17225919     DOI: 10.1007/s00394-006-0638-3

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  37 in total

1.  Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial.

Authors:  T A Dolecek
Journal:  Proc Soc Exp Biol Med       Date:  1992-06

2.  "Tall oil"-derived phytosterols reduce atherosclerosis in ApoE-deficient mice.

Authors:  M H Moghadasian; B M McManus; P H Pritchard; J J Frohlich
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-01       Impact factor: 8.311

3.  Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project.

Authors:  Sven O E Ebbesson; Patricia M Risica; Lars O E Ebbesson; John M Kennish; M Elizabeth Tejero
Journal:  Int J Circumpolar Health       Date:  2005-09       Impact factor: 1.228

4.  Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice.

Authors:  H R Davis; D S Compton; L Hoos; G Tetzloff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

5.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.

Authors:  Frank B Hu; Leslie Bronner; Walter C Willett; Meir J Stampfer; Kathryn M Rexrode; Christine M Albert; David Hunter; JoAnn E Manson
Journal:  JAMA       Date:  2002-04-10       Impact factor: 56.272

6.  Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation.

Authors:  William S Harris; Scott A Sands; Sheryl L Windsor; Hakim A Ali; Tracy L Stevens; Anthony Magalski; Charles B Porter; A Michael Borkon
Journal:  Circulation       Date:  2004-09-07       Impact factor: 29.690

7.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

8.  Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.

Authors:  Dick C Chan; Gerald F Watts; Trevor A Mori; P Hugh R Barrett; Trevor G Redgrave; Lawrence J Beilin
Journal:  Am J Clin Nutr       Date:  2003-02       Impact factor: 7.045

9.  The effect of dietary supplementation of fish oil on experimental myocardial infarction.

Authors:  B R Culp; W E Lands; B R Lucches; B Pitt; J Romson
Journal:  Prostaglandins       Date:  1980-12

10.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  7 in total

1.  Addition of aspirin to a fish oil-rich diet decreases inflammation and atherosclerosis in ApoE-null mice.

Authors:  Alexander V Sorokin; Zhi-Hong Yang; Boris L Vaisman; Seth Thacker; Zu-Xi Yu; Maureen Sampson; Charles N Serhan; Alan T Remaley
Journal:  J Nutr Biochem       Date:  2016-06-19       Impact factor: 6.048

Review 2.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

3.  Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice.

Authors:  Natalie D Riediger; Rgia Othman; Evelyn Fitz; Grant N Pierce; Miyoung Suh; Mohammed H Moghadasian
Journal:  Eur J Nutr       Date:  2008-05-03       Impact factor: 5.614

4.  Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.

Authors:  Amanda L Brown; Xuewei Zhu; Shunxing Rong; Swapnil Shewale; Jeongmin Seo; Elena Boudyguina; Abraham K Gebre; Martha A Alexander-Miller; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-07-19       Impact factor: 8.311

5.  The hypolipidemic effect of an ethyl ester of algal-docosahexaenoic acid in rats fed a high-fructose diet.

Authors:  Alan S Ryan; Eileen Bailey-Hall; Edward B Nelson; Norman Salem
Journal:  Lipids       Date:  2009-08-05       Impact factor: 1.880

6.  'Designer oils' low in n-6:n-3 fatty acid ratio beneficially modifies cardiovascular risks in mice.

Authors:  Natalie D Riediger; Nazila Azordegan; Sydney Harris-Janz; David W L Ma; Miyoung Suh; Mohammed H Moghadasian
Journal:  Eur J Nutr       Date:  2009-03-31       Impact factor: 5.614

7.  Caprylic acid suppresses inflammation via TLR4/NF-κB signaling and improves atherosclerosis in ApoE-deficient mice.

Authors:  Xinsheng Zhang; Changyong Xue; Qing Xu; Yong Zhang; Huizi Li; Feng Li; Yinghua Liu; Changjiang Guo
Journal:  Nutr Metab (Lond)       Date:  2019-06-06       Impact factor: 4.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.